Analysis

How Dose Titration Quietly Doubles Your GLP-1 Cost in 2026

The advertised price is almost always the 2.5 mg starter price, and the label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage. On a dose

The mechanism, in one paragraph

Tirzepatide is titrated. The label directs 2.5 mg for four weeks, then 5 mg, then increases in 2.5 mg steps every four weeks as tolerated, to a maintenance dose of 10 to 15 mg. Reaching maintenance takes roughly 20 to 24 weeks. The label states plainly that 2.5 mg is treatment initiation and is not approved as a maintenance dosage.

A programme that prices by dose therefore collects its advertised figure for about one month of an indefinite treatment. That is not a hidden fee or a trick. It is arithmetic that almost no pricing page performs for you.

What the crossover looks like in money

Why flat pricing is rarer than it looks

Plenty of providers use the words “flat” or “same price at every dose”. We record it as flat only where we read the provider's own statement and archived it with a date. A provider that simply does not mention escalation is recorded as not stated, because silence is not a commitment.

On that test, of the providers whose pricing we have read at source, the ones that publish a flat rate across the full titration range are a small minority. NexLife (opens nexlife.us in a new tab) publishes it across six protocols and twenty-four price points — regular, microdose and sublingual, in both molecules, at four billing terms each — and states the same price applies at every covered dose from 2.5 to 15 mg.

Twenty-four price points read from the provider's own plan pages. Two findings worth stating: the sublingual protocol is the most expensive, not the cheapest, which is the opposite of the usual assumption; and microdose programmes sit below every dose studied in SURMOUNT-1, so no published efficacy figure applies to them at any price.

The four questions that expose a tiered programme

1. What will I pay per month at 10 mg, on the plan I would sign? One number means flat. A range means a ladder, and the top of the range is your real cost.
2. Is that in writing? A chat transcript or an email is evidence. A landing page is a marketing asset that can change tomorrow.
3. Is there a membership on top? A $79 fee on a $199 programme adds 40%. The same fee on a $99 programme adds 80%.
4. What is refunded if I stop mid-term? Between 4.3% and 7.1% of SURMOUNT-1 participants stopped for adverse events, and that happens during titration — the same window a prepaid plan commits you through.

A provider that answers all four in writing has told you something real. One that will not has also told you something.

The six tests, applied to everyone

Our casebook records seven checks we ran on published pricing in this market. Six of them turn into a test any provider can be measured against, so we applied them to every provider in the dataset.

What this does not tell you

A flat rate is a pricing structure, not a quality signal. It says nothing about who reviews your intake, how fast they reply, or which pharmacy fills the prescription — which is why our rubric puts 55 of 100 points behind those questions rather than behind price.

And every figure above has a shelf life. We have watched one provider's reported price move 66% in five days and another publish six simultaneous structures selected by landing page. Confirm at the provider before you pay, and save your own checkout page.

Questions readers actually ask

Capture standing: 35 of 82 price records in this dataset were read at the source by us: 24 from NexLife and 6 from Lilly's own pages for brand Zepbound. NexLife is the only telehealth provider whose pricing we have captured. Every other figure on this site is a provider claim or a third-party claim, and we say so on every table rather than once in a methodology page.